Insulet (PODD) stock
NASDAQ
As of the Nov 5, 2026 close (U.S. Eastern)
Events and reference metrics · 1
- Market cap
- $10.8B
- As of Nov 5, 2026
- P/E
- 28.73x
- Trailing twelve months
- P/B
- 7.58x
- Latest reported equity
- P/S
- 3.53x
- Trailing twelve months
- ROE
- 26.4%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
- Market cap
- $10.8B
- As of Nov 5, 2026
- P/E
- 28.73x
- Trailing twelve months
- P/B
- 7.58x
- Latest reported equity
- P/S
- 3.53x
- Trailing twelve months
- ROE
- 26.4%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 5, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
28.73x
P/B
7.58x
P/S
3.53x
Earnings and dividend metrics▾
Earnings
EPS
$5.43
Earnings per share
BPS
$20.61
Book value per share
ROE
26.4%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $5.43 per share.
- BPS — net assets divided by the number of shares. Each share is backed by $20.61 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 26.4%.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 19.2% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Based on the company earnings press release. These figures come before the periodic report and may include adjusted measures.
Revenue · same quarter, three years
Year-ago quarter $706.3M+19.2%
From the company press release attached to an 8-K earnings filing. These figures come before the periodic report (10-Q or 10-K) and may include adjusted (non-GAAP) measures.
$544M
Jul–Sep '24
$706M
Jul–Sep '25
$842M
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 come from the company press release attached to an 8-K earnings filing submitted to SEC EDGAR on Nov 4, 2026.
- Press release figures come before the periodic report (10-Q or 10-K) and may include adjusted (non-GAAP) measures, so they can differ from later filings.
- Earnings per share increased 63.7% from the same quarter a year earlier.
- Revenue increased 19.2% from the same quarter a year earlier.
- Operating income increased 61.3% from the same quarter a year earlier.
- Net income increased 61.1% from the same quarter a year earlier.
Filed Nov 4, 2026 · 8-K · SEC EDGAR · View original
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Korean AI analysis available →Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Pease FlaviaEVP & CFO · Oct 1, 2026Shares withheld for taxes1,882 shares · $246KAvg. price $130.7917,357 shares held after
- Huffines Robert LutherDirector · Sep 30, 2026Grant or award178 shares · $23KAvg. price $130.472,627 shares held after
- MAZELSKY JONATHAN JAYDirector · Sep 30, 2026Grant or award141 shares · $18KAvg. price $130.471,496 shares held after
- McEvoy AshleyPresident and CEO · Aug 21, 2026Open-market purchase1,100 shares · $162KAvg. price $147.4723,731 shares held after
- Davis Lisa BlairSVP, Chief HR Officer · Aug 1, 2026Shares withheld for taxes244 shares · $40KAvg. price $165.354,453 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary8-KThe company said revenue for Q3 (3 months) was $842.0 million, up 19.2%, and rose 19.6% on a constant currency basis. Total Omnipod revenue for the same quarter was $836.6 million.Published Nov 4, 2026 · Filed Nov 4, 2026Read the summary →
- AI summary8-KThe company said it entered into a severance agreement and release with Ana M. Chadwick, former Chief Financial Officer, on February 27, 2026.Published Sep 30, 2026 · Filed Mar 4, 2026Read the summary →
- AI summary8-KInsulet said on January 29, 2026 it entered into an Addendum effective January 1, 2026 (the 2026 Addendum) with NXP USA, Inc. to the Purchase Agreement, dated October 12, 2017, as amended.Published Sep 30, 2026 · Filed Feb 3, 2026Read the summary →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Insulet (PODD) stock information
NASDAQ
Insulet (PODD) is listed on NASDAQ. Its market capitalization is about $10.8B. On trailing-twelve-month earnings the P/E ratio is 28.73, and the P/B ratio is 7.58. Return on equity is 26.4%. These figures are computed in-house from official filings and are reference information only.
Insulet — frequently asked questions
- What is the P/E ratio of Insulet (PODD)?
- On a trailing-twelve-month basis, PODD trades at a P/E ratio of 28.73. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Insulet?
- PODD has a market capitalization of about $10.8B. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.